Furthermore, results from patient cancer tissues cultured in 13C6-glucose or 13C5,15N2-glutamine tracers provided clear evidence of selective activation of PC over glutaminase (GLS) in NSCLC (Sellers et al., 2015). The gene discussed is GLS; the disease is cancer.